Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors. - Wikidata - wikimedia - TriplyDB

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

http://www.wikidata.org/entity/Q33543795

about

Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma Epigenetic impact of infection on carcinogenesis: mechanisms and applications Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.Genome-wide and gene-specific epigenomic platforms for hepatocellular carcinoma biomarker development trials.DNA methylation: potential biomarker in Hepatocellular Carcinoma.DNA methylation characteristics of primary melanomas with distinct biological behaviour.Effects on specific promoter DNA methylation in zebrafish embryos and larvae following benzo[a]pyrene exposure.Dynamic imbalance between cancer cell subpopulations induced by transforming growth factor beta (TGF-β) is associated with a DNA methylome switch.Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors.Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.Alcohol, DNA methylation, and cancer A nonparametric Bayesian approach for clustering bisulfate-based DNA methylation profiles.Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma.Integrative genomics identifies gene signature associated with melanoma ulceration.Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.Quality evaluation of methyl binding domain based kits for enrichment DNA-methylation sequencing.Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.Possible down regulation of the p16 gene promoter in individuals with hepatocellular carcinoma.Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.DNA markers in molecular diagnostics for hepatocellular carcinoma.Chronic liver inflammation modifies DNA methylation at the precancerous stage of murine hepatocarcinogenesis.Loss of DNA methylation at imprinted loci is a frequent event in hepatocellular carcinoma and identifies patients with shortened survival.Identifying CpG sites associated with eczema via random forest screening of epigenome-scale DNA methylation.Genome-wide DNA methylation profiles in hepatocellular carcinoma.DNA methylation loci associated with atopy and high serum IgE: a genome-wide application of recursive Random Forest feature selection.

P2860

Q26797616-0B3E00EC-B0E7-4EEA-84F9-54D703FBD564 Q26852716-9795D914-EAB9-4ED9-B5CB-863999EC6731 Q27023524-69D43AFB-C0B2-4C61-8260-555490455884 Q28066519-4FAC4271-328E-4954-8610-0C5C04E6576E Q28084553-8BA45468-81A6-498F-A1BF-6F3C4E464BE5 Q28383729-1741D0DC-C95B-47E2-A144-19A786214F08 Q28477432-25AA8520-9183-4737-8FBF-AA00AE9D1DA3 Q28730441-6BAAA829-4DA3-4972-B3B8-866937A86CBE Q30635373-3D681253-BE14-427F-882B-9335D0374CE5 Q31037974-B852E6DA-6E61-4844-AE55-227FD37CD117 Q31118547-7EB8156B-B4B2-4527-9CB1-D2FC82D29F75 Q33562782-4AC67967-5222-4E98-A398-7665B0DFD0C8 Q33617129-304E6B05-7F3B-48F7-8724-6F702AD8DAEB Q33617915-7A8AAD9B-68DB-42C3-AABB-BBB44C17487F Q33656372-4B456BC2-B11D-4E6B-8370-49C5B5A88CF2 Q33806379-9A779EED-0FBC-42C3-951C-1CB0AE6F5289 Q33826718-1F10A5A8-2032-4D0E-99ED-7D03202DF725 Q33905456-37FEB6D2-C7B7-411B-915E-8083E450E413 Q34004837-80033585-3533-44F6-9894-94A1127A44E9 Q34390179-45531802-5D1D-4E65-A859-33F765B57557 Q34470283-32C8C3C6-7D9B-4DA5-9390-1B9748A78F1D Q34525541-9A3C30F8-25FD-415A-BEAB-210AA74C1044 Q34575854-9478CA5F-13A0-438E-A53D-E750CF7CC4A3 Q34598189-A59468E7-F628-457A-8FA5-2431DD127A9B Q34648668-D5FA2FD9-921E-4A3D-950C-9C1E3BEA1BEB Q35000109-08E2C05B-BDDB-4DA3-9855-283F482879FE Q35270369-532C45F9-95DF-49B0-B75D-004E1CFE38C3 Q35339140-5EA6E847-375F-40DD-9549-DB8C7742D431 Q35368917-17B21304-DAF6-4DFE-BF31-434D8E740818 Q35532064-A3B1BBD6-8FB6-4DA1-8B3C-10FE11966FB1 Q35568894-D72BE02E-68D5-488F-8DE3-F5E6C7A718E6 Q35589600-E8BB5FDB-686A-49A9-9A52-1EE36B45A2BA Q35603750-0FB58293-6104-46C8-ACB8-A51B9B7A9920 Q35658932-DE76E907-F10F-4F04-9CA3-3AD8B6FBD739 Q35781255-C7FEA5A6-8CA2-4631-A5AD-98E73F301CB6 Q35793705-14A83308-A93A-4948-B372-72E8E847B68E Q35809876-C05D8047-1524-4320-8951-24BD78F61DE6 Q35869661-D63C4B37-07FA-414A-BC5F-0C173DA77174 Q35899166-E095A3CA-A753-4230-A22E-F460ECFA6731 Q35985979-7C8D3BBC-D5FF-4C3C-B207-E4CC18C782AD

P2860

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

http://www.wikidata.org/entity/Q33543795

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@ast

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@en

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@nl

type

label

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@ast

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@en

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@nl

prefLabel

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@ast

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@en

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@nl

P1433

Q33543795-344AFEA6-BC65-4235-9915-1D0F05779EB6

P1476

Q33543795-F3D1531F-26B8-4C5E-92EF-C8297EEE17CF

P2093

Q33543795-1169BD2C-7360-4684-9FB3-24FBCBFAA620

Q33543795-52F1C2A3-9B31-4689-9F1D-03AFDE087C13

Q33543795-9F83D838-12D8-4BC7-A473-A561CBCB2A8C

Q33543795-D3DCCCC2-3626-4BCA-8843-C4D5B6C4D1CB

Q33543795-F6D1F8EB-4955-4747-93F7-25D4C5B3A0D0

P2860

Q33543795-0D93DC85-F73F-4769-8ED4-088BCF2BE4B1

Q33543795-1C19B257-EEFC-4229-AEB2-49D5D9A49FA2

Q33543795-1D9187C1-F4A0-4B7D-AAB1-2B5F753B800E

Q33543795-21CD8840-003F-41ED-87C8-97F74D18A871

Q33543795-2EC1E9FC-69BD-4C65-9E51-80932947EBB5

Q33543795-3535DBC4-D8A4-4D85-B04F-982DE776F526

Q33543795-35B2F38D-88EA-48C2-91CD-AA4847ABAD04

Q33543795-3B361B0D-429C-455A-BB41-9FFD2C554FB1

Q33543795-43323ED8-21AB-4838-9728-EB0ADFED61DE

Q33543795-4EE813F8-9443-44FE-BD83-57C5494B2D32

P304

Q33543795-CDFDA917-0C6E-4BCE-8FD6-29A4F3FFFA3C

P31

Q33543795-A7B49F52-4248-46B4-B2D9-1774DEA52BCE

P356

Q33543795-C6A834F6-719B-454D-AAE1-1E28D442EED5

P407

Q33543795-00F5ABF1-50D4-4413-92B9-F3A8903EC56E

P433

Q33543795-D4728BF2-746D-431D-9F79-29FC8DC9CDB3

P478

Q33543795-C632BF2C-61E8-464D-9D50-0067DBA80C56

P50

Q33543795-2F283A28-F23F-4C46-8CEC-77EE95D0160D

Q33543795-3FA4B89F-122D-439B-B8F2-3895BFA84880

Q33543795-6DF95A90-F1F3-416A-9E6C-78096FDEA2FF

Q33543795-84362524-A524-439A-B1DE-59A8D8EBDDA6

Q33543795-979D310F-F66E-4A0C-9F34-F6DD4AB9C298

P577

Q33543795-D17F2B7E-7BB2-4319-BAF4-D29400A8539C

P5875

Q33543795-DDCFD460-B41C-41F9-B391-E69703AC7A23

P698

Q33543795-2B63D7E8-3666-4A91-9464-AD2F03328D2E

P921

Q33543795-F059A25A-9BCF-4335-8F6C-B90903456DEA

P932

Q33543795-737E5E75-A79E-4317-A26D-1CDD90843487

P356

JOURNAL.PONE.0009749

P1433

P1476

Hepatocellular carcinoma displ ...... ential as clinical predictors.

@en

P2093

Florence Le Calvez-Kelm

http://www.w3.org/2001/XMLSchema#string

Géraldine Gouysse

http://www.w3.org/2001/XMLSchema#string

Sandrine McKay-Chopin

http://www.w3.org/2001/XMLSchema#string

Sean V Tavtigian

http://www.w3.org/2001/XMLSchema#string

Zdenko Herceg

http://www.w3.org/2001/XMLSchema#string

P2860

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

Host epigenetic modifications by oncogenic viruses

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

The fundamental role of epigenetic events in cancer

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Multiclass cancer diagnosis using tumor gene expression signatures

Mechanisms of hepatic fibrogenesis

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data.

P304

e9749

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0009749

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Yves Scoazec

Hector Hernandez-Vargas

Marie-Pierre Lambert

P577

2010-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42372781

http://www.w3.org/2001/XMLSchema#string

P698

20305825

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

2840036

http://www.w3.org/2001/XMLSchema#string